Key result
Transcutaneous vagus nerve stimulation increased exercise capacity by 1.04 mL/kg/min compared to no significant change with sham stimulation.
Why the study?
Vagal parasympathetic dysfunction is linked to impaired exercise tolerance, but whether non-invasive transcutaneous vagus nerve stimulation can improve exercise capacity in humans remained unproven.
Does non-invasive transcutaneous vagus nerve stimulation improve peak oxygen consumption in healthy volunteers?
RCT (n=28)
Double-blind
crossover
No
Does non-invasive transcutaneous vagus nerve stimulation improve peak oxygen consumption in healthy volunteers?
Non-invasive transcutaneous vagus nerve stimulation applied daily for 7 days significantly improves peak oxygen consumption and exercise capacity in healthy volunteers.
Answers are grounded in this paper and cite their sources.
tVNS improves VO2peak in healthy volunteers; extends autonomic neuromodulation to exercise capacity and supports trials in HF or sedentary patients.
BACKGROUND AND AIMS: Vagal parasympathetic dysfunction is strongly associated with impaired exercise tolerance, indicating that coordinated autonomic control is essential for optimizing exercise performance. This study tested the hypothesis that autonomic neuromodulation by non-invasive transcutaneous vagus nerve stimulation (tVNS) can improve exercise capacity in humans. METHODS: This single-centre, randomized, double-blind, sham-controlled, crossover trial in 28 healthy volunteers evaluated the effect of bilateral transcutaneous stimulation of vagal auricular innervation, applied for 30 min daily for 7 days, on measures of cardiorespiratory fitness (peak oxygen consumption (VO2peak)) during progressive exercise to exhaustion. Secondary endpoints included peak work rate, cardiorespiratory measures, and the whole blood inflammatory response to lipopolysaccharide ex vivo. RESULTS: tVNS applied for 30 min daily over 7 consecutive days increased VO2peak by 1.04 mL/kg/min (95% CI: .34-1.73; P = .005), compared with no change after sham stimulation (-0.54 mL/kg/min; 95% CI: -1.52 to .45). No carry-over effect was observed following the 2-week washout period. tVNS increased work rate (by 6 W; 95% CI: 2-10; P = .006), heart rate (by 4 bpm; 95% CI: 1-7; P = .011), and respiratory rate (by 4 breaths/min; 95% CI: 2-6; P < .001) at peak exercise. Analysis of the whole blood transcriptomic response to lipopolysaccharide in serial samples obtained from five participants showed that tVNS reduced the inflammatory response. CONCLUSIONS: Non-invasive vagal stimulation improves measures of cardiorespiratory fitness and attenuates inflammation, offering an inexpensive, safe, and scalable approach to improve exercise capacity.
No takes yet. Share an insight, caveat, or question.
Ackland et al. (2025) conducted an RCT in healthy volunteers (n=28). transcutaneous vagus nerve stimulation (tVNS) vs. sham stimulation was evaluated on peak oxygen consumption (VO2peak) during progressive exercise to exhaustion (1.04 mL/kg/min increase, 95% CI 0.34-1.73, p=.005). Transcutaneous vagus nerve stimulation increased exercise capacity by 1.04 mL/kg/min compared to no significant change with sham stimulation.
Synapse has enriched 10 related papers. Consider them for comparative context: